SEARCH

SEARCH BY CITATION

References

  • 1
    Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic Rhinitis and its Impact on Asthma (ARIA). J Allergy Clin Immunol 2001;108(5 Pt 2):S147334.
  • 2
    Group IRMW. International Consensus Report on the diagnosis and management of rhinitis. Allergy 1994;49(Suppl. 19):S134.
  • 3
    Dykewicz MS, Fineman S, Skoner DP, Nicklas R, Lee R, Blessing-Moore J et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998; 81(5 Pt 2):478518.
  • 4
    Fokkens WJ. Thoughts on the pathophysiology of nonallergic rhinitis. Curr Allergy Asthma Rep 2002;2: 203209.
  • 5
    Bachert C. Persistent rhinitis – allergic or nonallergic? Allergy 2004; 59(Suppl. 76):1115.
  • 6
    Slavin RG. Occupational rhinitis. Ann Allergy Asthma Immunol 1999;83(6 Pt 2):597601.
  • 7
    Saria A. Neuroimmune interactions in the airways: implications for asthma, allergy, and other inflammatory airway diseases. Brain Behav Immun 1988;2: 318321.
  • 8
    Leroyer C, Malo JL, Girard D, Dufour JG, Gautrin D. Chronic rhinitis in workers at risk of reactive airways dysfunction syndrome due to exposure to chlorine. Occup Environ Med 1999;56: 334338.
  • 9
    Shusterman D, Balmes J. Measurement of nasal irritant sensitivity to pulsed carbon dioxide: a pilot study. Arch Environ Health 1997;52: 334340.
  • 10
    Graf P. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity. Rhinology 1996;34: 913.
  • 11
    Graf P. Rhinitis medicamentosa: aspects of pathophysiology and treatment. Allergy 1997;52(Suppl. 40):2834.
  • 12
    Kaufman HS. Timolol-induced vasomotor rhinitis: a new iatrogenic syndrome [Letter]. Arch Ophthalmol 1986;104: 970.
  • 13
    Mabry RL. Nasal stuffiness due to systemic medications. Otolaryngol Head Neck Surg 1982;91: 9394.
  • 14
    Incaudo G, Schatz M. Rhinosinusitis associated with endocrine conditions: hypothyroidism and pregnancy. In: SchatzM, SettipaneGA, eds. Nasal manifestations of systemic diseases. Providence, RI, USA: Oceanside, 1991; 54.
  • 15
    Ellegard E, Karlsson G. Nasal congestion during pregnancy. Clin Otolaryngol 1999;24: 307311.
  • 16
    Navarrete-Palacios E, Hudson R, Reyes-Guerrero G, Guevara-Guzman R. Correlation between cytological characteristics of the nasal epithelium and the menstrual cycle. Arch Otolaryngol Head Neck Surg 2003;129: 460463.
  • 17
    Malmberg H, Grahne B, Holopainen E, Binder E. Ipratropium (Atrovent) in the treatment of vasomotor rhinitis of elderly patients. Clin Otolaryngol 1983;8: 273276.
  • 18
    Dockhorn R, Aaronson D, Bronsky E, Chervinsky P, Cohen R, Ehtessabian R et al. Ipratropium bromid nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. Ann Allergy Asthma Immunol 1999;82: 349359.
  • 19
    Jacobs RL, Freedman PM, Boswell RN. Nonallergic rhinitis with eosinophilia (NARES syndrome). Clinical and immunologic presentation. J Allergy Clin Immunol 1981;67: 253262.
  • 20
    Mikaelian AJ. Vasomotor rhinitis [Review]. Ear Nose Throat J 1989; 68: 207210.
  • 21
    Moneret-Vautrin DA, Hsieh V, Wayoff M, Guyot JL, Mouton C, Maria Y. Nonallergic rhinitis with eosinophilia syndrome a precursor of the triad: nasal polyposis, intrinsic asthma, and intolerance to aspirin. Ann Allergy 1990;64: 513518.
  • 22
    Ingels K, Durdurez JP, Cuvelier C, Van Cauwenberge P. Nasal biopsy is superior to nasal smear for finding eosinophils in nonallergic rhinitis. Allergy 1997;52: 338341.
  • 23
    Blom HM, Godthelp T, Fokkens WF, KleinJan A, Mulder PGM, Rijntjes E. The effect of nasal steroid aqueous spray on nasal complaint scores and cellular infiltrates in the nasal mucosa of patients with a non-allergic non-infectious perennial rhinitis. J Allergy Clin Immunol 1997;100: 739747.
  • 24
    Numata T, Konno A, Hasegawa S, Hanazawa T, Nagata H, Motosugi H et al. Pathophysiological features of the nasal mucosa in patients with idiopathic rhinitis compared to allergic rhinitis. Int Arch Allergy Immunol 1999;119: 304313.
  • 25
    Powe DG, Huskisson RS, Carney AS, Jenkins D, Jones NS. Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy 2001;31: 864872.
  • 26
    Platts-Mills TA. Local production of IgG, IgA and IgE antibodies in grass pollen hay fever. J Immunol 1979; 122: 22182225.
  • 27
    KleinJan A, Vinke JG, Severijnen LW, Fokkens WJ. Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J 2000;15: 491497.
  • 28
    Durham SR, Gould HJ, Thienes CP, Jacobson MR, Masuyama K, Rak S et al. Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol 1997;27: 28992906.
  • 29
    Small P, Black M, Frenkiel S. Effects of treatment with beclomethasone dipropionate in subpopulations of perennial rhinitis patients. J Allergy Clin Immunol 1982;70: 178182.
  • 30
    Vinke JG, KleinJan A, Severijnen LW, Fokkens WJ. Passive smoking causes an ’allergic’ cell infiltrate in the nasal mucosa of non-atopic children. Int J Pediatr Otorhinolaryngol 1999;51: 7381.
  • 31
    Villar MT, Holgate ST. IgE, smoking and lung function. Clin Exp Allergy 1995;25: 206209.
  • 32
    Rennard SI, Umino T, Millatmal T, Daughton DM, Manouilova LS, Ullrich FA et al. Evaluation of subclinical respiratory tract inflammation in heavy smokers who switch to a cigarette-like nicotine delivery device that primarily heats tobacco. Nicotine Tob Res 2002;4: 467476.
  • 33
    Bouwhuijsen ECA, Dijkstra MD, Severijnen LW, KleinJan A, Fokkens WJ. Effects of cigarette smoking on nasal mucosa inflammation. Allergologie 1996;19: 56.
  • 34
    Sanico A, Togias A. Noninfectious, nonallergic rhinitis (NINAR): considerations on possible mechanisms. Am J Rhinol 1998;12: 6572.
  • 35
    Blom HM, Van Rijswijk JB, Garrelds IM, Mulder PG, Timmermans T, Gerth van Wijk R. Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. A placebo-controlled study. Clin Exp Allergy 1997;27: 796801.
  • 36
    Blom HM, Godthelp T, Fokkens WJ, KleinJan A, Holm AF, Vroom TM et al. Mast cells, eosinophils and IgE-positive cells in the nasal mucosa of patients with vasomotor rhinitis. An immunohistochemical study. Eur Arch Otorhinolaryngol Suppl 1995;1: S3339.
  • 37
    Mygind N, Weeke B. Allergic and vasomotor rhinitis: clinical aspects. Copenhagen, Denmark: Munksgaard, 1985.
  • 38
    Gerth van Wijk R, Dieges PH. Nasal reactivity to histamine and methacholine: two different forms of upper airway responsiveness. Rhinology 1994;32: 119122.
  • 39
    Togias A, Lykens K, Kagey-Sobotka A, Eggleston PA, Proud D, Lichtenstein LM et al. Studies on the relationships between sensitivity to cold, dry air, hyperosmolal solutions, and histamine in the adult nose. Am Rev Respir Dis 1990;141: 14281433.
  • 40
    Braat JP, Mulder PG, Fokkens WJ, Gerth van Wijk R, Rijntjes E. Intranasal cold dry air is superior to histamine challenge in determining the presence and degree of nasal hyperreactivity in nonallergic noninfectious perennial rhinitis. Am J Respir Crit Care Med 1998;157(6 Pt 1):17481755.
  • 41
    Sanico AM, Philip G, Proud D, Naclerio RM, Togias A. Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: effects of capsaicin nasal challenge. Clin Exp Allergy 1998;28: 92100.
  • 42
    Togias AG, Naclerio RM, Proud D et al. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest 1985;76: 13751381.
  • 43
    Shatkin JS, Delsupehe KG, Thisted RA, Corey JP. Mucosal allergy in the absence of systemic allergy in nasal polyposis and rhinitis: a meta-analysis. Otolaryngol Head Neck Surg 1994;111: 553556.
  • 44
    Philip G, Togias AG. Nonallergic rhinitis. Pathophysiology and models for study. Eur Arch Otorhinolaryngol Suppl 1995;1: S2732.
  • 45
    Carney AS, Jones NS. Idiopathic rhinitis: idiopathic or not? Clin Otolaryngol 1996;21: 198202.
  • 46
    Garay R. Mechanisms of vasomotor rhinitis. Allergy 2004;59(Suppl. 76):410.
  • 47
    Bentley AM, Jacobson MR, Cumberworth V, Barkans JR, Moqbel R, Schwartz LB et al. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells. J Allergy Clin Immunol 1992;89: 877883.
  • 48
    Fokkens WJ, Holm AF, Rijntjes E, Mulder PG, Vroom TM. Characterization and quantification of cellular infiltrates in nasal mucosa of patients with grass pollen allergy, non-allergic patients with nasal polyps and controls. Int Arch Allergy Appl Immunol 1990;93: 6672.
  • 49
    Braunstahl GJ, Overbeek SE, Fokkens WJ, KleinJan A, McEuen AR, Walls AF et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 2001;164: 858865.
  • 50
    Van Rijswijk JB, Blom HM, KleinJan A, Mulder PGH, Rijntjes E, Fokkens WJ. Inflammatory cells seem not to be involved in idiopathic rhinitis. Rhinology 2003;41: 2530.
  • 51
    Lundblad L, Sipila P, Farstad T, Drozdziewicz D. Mometasone furoate nasal spray in the treatment of perennial non-allergic rhinitis: a nordic, multicenter, randomized, double-blind, placebo-controlled study. Acta Otolaryngol 2001;121: 505509.
  • 52
    Blom HM, Severijnen LA, Van Rijswijk JB, Mulder PG, Gerth van Wijk R, Fokkens WJ. The long-term effects of capsaicin aqueous spray on the nasal mucosa. Clin Exp Allergy 1998;28: 13511358.
  • 53
    Gerth Van Wijk R, Terreehorst IT, Mulder PG, Garrelds IM, Blom HM, Popering S. Intranasal capsaicin is lacking therapeutic effect in perennial allergic rhinitis to house dust mite. A placebo-controlled study. Clin Exp Allergy 2000;30: 17921798.
  • 54
    Baraniuk JN. Sensory, parasympathetic, and sympathetic neural influences in the nasal mucosa. J Allergy Clin Immunol 1992;90(6 Pt 2):10451050.
  • 55
    Malcomson KG. The vasomotor activities of the nasal mucous membrane. J Laryngol 1959;73: 7375.
  • 56
    Lung MA. The role of the autonomic nerves in the control of nasal circulation. Biol Signals 1995;4: 179185.
  • 57
    Kimmelman CP, Ali GH. Vasomotor rhinitis. Otolaryngol Clin North Am 1986;19: 6571.
  • 58
    Jones AS, Lancer JM. Vasomotor rhinitis [Editorial]. Br Med J 1987;294: 15051506.
  • 59
    Van Megen YJB. Neuroreceptors in nasal allergy. Nijmegen, the Netherlands: University of Nijmegen, 1989.
  • 60
    Wilde AD, Cook JA, Jones AS. The nasal response to isometric exercise in non-eosinophilic intrinsic rhinitis. Clin Otolaryngol 1996;21: 8486.
  • 61
    Wilde AD, Jones AS. The nasal response to axillary pressure. Clin Otolaryngol 1996;21: 442444.
  • 62
    Lundblad L, Lundberg JM, Brodin E, Anggard A. Origin and distribution of capsaicin-sensitive substance-P-immunoreactive nerves in the nasal mucosa. Acta Otolaryngol 1983;96: 485493.
  • 63
    Uddman R, Alumets J, Densert O, Hakansson R, Sundler F. Occurrence and distribution of VIP nerves in the nasal mucosa and the tracheobronchial wall. Acta Otolaryngol 1978;85: 443448.
  • 64
    Baraniuk JN. Neuropeptides. Am J Rhinol 1998;12: 916.
  • 65
    Baraniuk JN, Kaliner MA. Neuropeptides and nasal secretion. J Allergy Clin Immunol 1990;86(4 Pt 2):620627.
  • 66
    Fang SY, Shen CL. Neuropeptide innervation and neuroendocrine cells in allergic rhinitis and chronic hypertrophic rhinitis. Clin Exp Allergy 1998;28: 228232.
  • 67
    Lacroix JS, Kurt AM, Pochon N, Bretton C, Lunberg JM, Deshusses J. Neutral endopeptidase activity and concentration of sensory neuropeptide in the human nasal mucosa. Eur Arch Otorhinolaryngol 1995;252: 465468.
  • 68
    Svensson C, Andersson M, Greiff L, Persson CG. Nasal mucosal endorgan hyperresponsiveness. Am J Rhinol 1998;12: 3743.
  • 69
    Anggard A. Basic mechanisms in autonomic nervous responses in specific and nonspecific nasal hyperreactivity. Acta Otolaryngol 1993;113: 394396.
  • 70
    Sanico AM, Atsuta S, Proud D, Togias A. Dose-dependent effects of capsaicin nasal challenge: in vivo evidence of human airway neurogenic inflammation. J Allergy Clin Immunol 1997;100: 632641.
  • 71
    Jancso N, Jancso-Gabor A, Szolcsanyi J. Direct evidence of neurogenic inflammation and its prevention by denervation and pretreatment with capsaicin. Br J Pharmacol Chemother 1967;31: 138151.
  • 72
    Holzer P. Local effector functions of capsaicin sensitive nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988;24: 739768.
  • 73
    Lundblad L, Saria A, Lundberg JM, Anggard A. Increased vascular permeability in rat nasal mucosa induced by substance P and stimulation of capsaicin-sensitive trigeminal neurons. Acta Otolaryngol 1983;96(5–6):479484.
  • 74
    Holzer P. Capsaicin; cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991;43: 143201.
  • 75
    Kitajiri M, Kubo N, Ikeda H, Sato K, Kumazawa T. Effects of topical capsaicin on autonomic nerves in experimentally-induced nasal hypersensitivity. An immunocytochemical study. Acta Otolaryngol Suppl 1993;500: 8891.
  • 76
    Wolf G. New aspects in the pathogenesis and therapy of hyperreflexive rhinopathy. Laryngol Rhinol Otol (Stuttg) 1988;67: 438445.
  • 77
    Lacroix JS, Buvelot JM, Polla BS, Lundberg JM. Improvement of symptoms of non-allergic chronic rhinitis by local treatment with capsaicin. Clin Exp Allergy 1991;21: 595600.
  • 78
    Lacroix JS, Pochon N, Lundberg JM. Increased concentration of sensory neuropeptide in the nasal mucosa from patients with non-allergic chronic rhinitis. In: The new frontiers of otorhinolaryngology in Europe (II). Sorrento, Italy: Monduzzi Editore S.p.A., 1992: 5963.
  • 79
    Wolf G, Anderhuber W, Hauser-Kronberger C, Saria A. Treatment of nonspecific hyper-reflectory rhinopathy (vasomotor rhinitis) with capsaicin. Laryngorhinootologie 1995;74: 289293.
  • 80
    Riechelmann H, Davris S, Bader D. Treatment of perennial non-allergic rhinopathy with capsaicin. HNO 1993;41: 475479.
  • 81
    Marabini S, Ciabatti PG, Polli G, Fusco BM, Geppetti P. Beneficial effects of intranasal applications of capsaicin in patients with vasomotor rhinitis. Eur Arch Otorhinolaryngol 1991;248: 191194.
  • 82
    Van Rijswijk JB, Boeke EL, Keizer JM, Mulder PGH, Blom HM, Fokkens WJ. Intranasal capsaicin reduces nasal hyperreactivity in idiopathic rhinitis: a double-blind randomised application regimen study. Allergy 2003;58: 754761.
  • 83
    Ruffoli R, Fattori B, Giambelluca MA, Soldani P, Giannessi F. Ultracytochemical localization of the NADPH-d activity in the human nasal respiratory mucosa in vasomotor rhinitis. Laryngoscope 2000;110: 13611365.
  • 84
    Broms P, Malm L. Oral vasoconstrictors in perennial non-allergic rhinitis. Allergy 1982;37: 6774.
  • 85
    Lieberman P. Treatment update: nonallergic rhinitis. Allergy Asthma Proc 2001;22: 199202.
  • 86
    Wight RG, Jones AS, Beckingham E, Andersson B, Ek L. A double blind comparison of intranasal budesonide 400 micrograms and 800 micrograms in perennial rhinitis. Clin Otolaryngol 1992;17: 354358.
  • 87
    Scadding GK, Lund VJ, Jacques LA, Richards DH. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic perennial rhinitis. Clin Exp Allergy 1995;25: 737743.
  • 88
    Banov CH, Lieberman P. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol 2001;86: 2835.
  • 89
    Gehanno P, Deschamps E, Garay E, Baehre M, Garay RP. Vasomotor rhinitis: clinical efficacy of azelastine nasal spray in comparison with placebo. ORL J Otorhinolaryngol Relat Spec 2001;63: 7681.
  • 90
    Ciprandi G. Treatment of nonallergic perennial rhinitis. Allergy 2004;59(Suppl. 76):1623.
  • 91
    Tan R, Corren J. Optimum treatment of rhinitis in the elderly. Drugs Aging 1995;7: 168175.
  • 92
    Jones AS, Lancer JM, Moir AA, Stevens JC. The effect of submucosal diathermy to the inferior turbinates on nasal resistance to airflow in allergic and vasomotor rhinitis. Clin Otolaryngol 1985;10: 249252.
  • 93
    McCombe AW, Cook J, Jones AS. A comparison of laser cautery and sub-mucosal diathermy for rhinitis. Clin Otolaryngol 1992;17: 297299.
  • 94
    Moore JR, Bicknell PG. A comparison of cryosurgery and submucous diathermy in vasomotor rhinitis. J Laryngol Otol 1980;94: 14111413.
  • 95
    Al-Samarrae SM. Treatment of ‘vasomotor rhinitis’ by the local application of silver nitrate. J Laryngol Otol 1991;105: 285287.
  • 96
    Ibragimov GT, Rasunova AK. Treatment of patients with vasomotor rhinitis using snake venom [Russian]. Vestn Otorinolaringol 1987;1: 3941.
  • 97
    Golding-Wood PH. Vidian neurectomy and other trans-antral surgery – 1970. Laryngoscope 1970;80: 11791189.
  • 98
    Golding-Wood PH. Vidian neurectomy: its results and complications. Laryngoscope 1973;83: 16731683.
  • 99
    Grote JJ. The autonomic innervation of the nasal mucosa. Nijmegen, the Netherlands: University of Nijmegen, 1974.
  • 100
    Krajina Z. Critical review of vidian neurectomy [Review]. Rhinology 1989;27: 271276.
  • 101
    Krant JN, Wildervanck de Blecourt P, Dieges PH, de Heer LJ. Long-term results of vidian neurectomy. Rhinology 1979;17: 231235.